Skip to content
20-F

Annual Report (Foreign)

SINOVAC BIOTECH LTD SVA

0001193125-26-258534

← back to feed
Filed
Jun 5, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 71.86M sh
Shares Diluted FY 2025 · Dec 31, 2024 71.86M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 71.85M sh
Shares Outstanding FY 2025 · Dec 31, 2025 71.86M sh
Dividends Paid FY 2025 · Dec 31, 2025 $3.3B
Capex FY 2025 · Dec 31, 2025 $48.92M
Capex FY 2025 · Dec 31, 2024 $95.96M
Capex FY 2025 · Dec 31, 2023 $156.17M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$512.18M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$56.89M
Operating Cash Flow restated FY 2025 · Dec 31, 2023 $138.65M
Long Term Debt FY 2025 · Dec 31, 2025 $494.86M
Short Term Investments FY 2025 · Dec 31, 2025 $5.48B
Short Term Investments FY 2025 · Dec 31, 2024 $9.61B
Cash And Equivalents FY 2025 · Dec 31, 2025 $488.25M
Cash And Equivalents FY 2025 · Dec 31, 2024 $335.27M
Stockholders Equity FY 2025 · Dec 31, 2025 $4.44B
Stockholders Equity FY 2025 · Dec 31, 2024 $8.26B
Current Liabilities FY 2025 · Dec 31, 2025 $1.54B
Current Liabilities FY 2025 · Dec 31, 2024 $1.45B
Total Liabilities FY 2025 · Dec 31, 2025 $2.15B
Total Liabilities FY 2025 · Dec 31, 2024 $2.04B
Current Assets FY 2025 · Dec 31, 2025 $7.06B
Current Assets FY 2025 · Dec 31, 2024 $10.64B
Total Assets FY 2025 · Dec 31, 2025 $8.54B
Total Assets FY 2025 · Dec 31, 2024 $12.34B
Eps Diluted FY 2025 · Dec 31, 2025 −$0.83
Eps Diluted FY 2025 · Dec 31, 2024 $1.27
Eps Diluted restated FY 2025 · Dec 31, 2023 −$0.19
Eps Basic FY 2025 · Dec 31, 2025 −$0.83
Eps Basic FY 2025 · Dec 31, 2024 $1.27
Eps Basic restated FY 2025 · Dec 31, 2023 −$0.19
Sga Expense FY 2025 · Dec 31, 2025 $332.98M
Sga Expense FY 2025 · Dec 31, 2024 $420.92M
Sga Expense restated FY 2025 · Dec 31, 2023 $598.25M
Rd Expense FY 2025 · Dec 31, 2025 $216.18M
Rd Expense FY 2025 · Dec 31, 2024 $270.66M
Rd Expense restated FY 2025 · Dec 31, 2023 $350.19M
Operating Income FY 2025 · Dec 31, 2025 −$490.13M
Operating Income FY 2025 · Dec 31, 2024 −$505.54M
Operating Income restated FY 2025 · Dec 31, 2023 −$713.98M
Gross Profit FY 2025 · Dec 31, 2025 $261.98M
Gross Profit FY 2025 · Dec 31, 2024 $220.69M
Gross Profit restated FY 2025 · Dec 31, 2023 $323.32M
Cost Of Revenue FY 2025 · Dec 31, 2025 $124.03M
Cost Of Revenue FY 2025 · Dec 31, 2024 $140.69M
Cost Of Revenue restated FY 2025 · Dec 31, 2023 $146.85M
Revenue FY 2025 · Dec 31, 2025 $386.01M
Revenue FY 2025 · Dec 31, 2024 $361.37M
Revenue restated FY 2025 · Dec 31, 2023 $470.17M